David M. Rosen
Ph.D.
Operations and Product Development
David M. Rosen has over 25 years of experience in the pharmaceutical, biotechnology, and medical device industries and has served on the management teams for both public and private companies for the last 15 years. His experience covers both research and development, including preclinical development, CMC, and project management. Teams he has led, managed, or participated in have covered the spectrum from discovery of novel therapeutic candidates through completion of phase 3 clinical trials in both the US and Europe. Therapeutics being developed has included small molecules, synthetic peptides, as well as recombinant proteins. Therapeutic areas have a wide array of indications including orthopedics (bone and cartilage repair), osteoporosis, ophthalmology, cardiovascular, nephrology and associated complications, diabetes, and dental indications.
Dr. Rosen began his career at Collagen Corporation, a medical device company, where he held scientific and project management positions working on orthopedic, dental, and soft tissue augmentation programs. His career continued with Celtrix Pharmaceuticals after it spun off from Collagen Corp enabling him to expand his experience in the CMC and facilities areas. At Celtrix, development programs included diabetes, would healing, and ophthalmology where he concluded as Sr. Vice President R&D. He then spent approximately 3 1/2 years at Hyseq Pharmaceuticals where, as Vice President of Operations, he had responsibilities for preclinical development, CMC, and facilities. Most recently, he was Sr. Vice President of R&D at Acologix Inc, where development programs included bone and cartilage repair, dental repair, and conditions associated with complications of renal failure (hyperphsphatemia and uremic pruritius). Dr. Rosen received his Ph.D. in biochemistry at the University of California, Riverside.
If you need more assistance in determining which of our experienced consultants might best fit your needs, please contact us.
